|Bid||1.5800 x 800|
|Ask||1.5900 x 1200|
|Day's range||1.5500 - 1.6200|
|52-week range||1.0900 - 4.7000|
|Beta (5Y monthly)||-0.22|
|PE ratio (TTM)||N/A|
|Earnings date||14 Nov 2022 - 18 Nov 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||14.50|
Highlights Merrimack Pharmaceuticals, Moderna and Seagen are included in this Analyst Blog.
Pipeline updates from MACK and MRNA are the key highlights from the biotech sector during the past week.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...